Aclaración de la evidencia sobre las pruebas rápidas de antígeno del SARS-CoV-2 en las respuestas de salud pública al

Michael J Mina1, Tim E Peto2, Marta García-Fiñana3

  • 1Center for Communicable Disease Dynamics, Department of Epidemiology and Department of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health and Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Lancet (London, England)
|February 20, 2021
PubMed
Resumen

No abstract available in PubMed .